J. Goldman & CO LP Veru Inc. Transaction History

J. Goldman & CO LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.76 - $1.79 $946,542 - $2.23 Million	-1,245,451 Reduced 90.22%	135,000 $113,000
Q1 2024 May 15, 2024	SELL	$0.37 - $0.72 $84,008 - $163,475	-227,049 Reduced 14.12%	1,380,451 $966,000
Q4 2023 Feb 14, 2024	BUY	$0.67 - $1.17 $1.08 Million - $1.88 Million	1,607,500 New	1,607,500 $1.16 Million

122

56.9M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $50.5M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.